Tobacco Use Is Associated with Readmission within 90 Days after Craniotomy.
Clin Neurol Neurosurg
; 200: 106383, 2021 01.
Article
em En
| MEDLINE
| ID: mdl-33296843
ABSTRACT
OBJECTIVE:
Tobacco use increases morbidity and mortality following craniotomy. Readmission is an important hospital metric of patient outcomes and has been used to inform reimbursement. This study aims to determine if tobacco use is associated with readmission within 90 days of hospital discharge among patients undergoing elective craniotomy.METHODS:
The Nationwide Readmissions Database (NRD), a population-based, nationally representative database, was queried from 2010-2014. Patients undergoing craniotomy for benign or malignant tumors, vascular pathologies, and epilepsy were identified. Readmissions within 90 days of index hospitalization were characterized by admitting diagnoses. Tobacco use was defined by ICD-9 coding for active or prior use. Descriptive and multivariable regression analyses evaluated patient and hospital factors associated with readmission.RESULTS:
The study population included 77,903 patients treated with craniotomy. Of these, 17,674 (22.6%) were readmitted within 90 days. The most common reasons for readmission were post-operative infection (5.8%), septicemia (4.2%), pulmonary embolism (3.9%), and pneumonia (2.9%). Tobacco use was associated with a 7% increased likelihood of 90-day readmission (OR 1.07, 95% CI 1.03-1.11, pâ¯=â¯0.0008) after accounting for other patient-, disease-, and hospital-level factors in multivariate analysis.CONCLUSIONS:
Tobacco use was associated with increased 90-day readmission in patients undergoing craniotomy. Recognizing tobacco use as a modifiable risk factor of readmission presents an opportunity to identify susceptible patients.Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Readmissão do Paciente
/
Complicações Pós-Operatórias
/
Craniotomia
/
Uso de Tabaco
Idioma:
En
Ano de publicação:
2021
Tipo de documento:
Article